Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/mus.26921 http://scihub22266oqcxt.onion/10.1002/mus.26921 32415876!ä!32415876 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Muscle+Nerve 2020 ; 62 (3): 321-326 Nephropedia Template TP {{tp|p=32415876|t=2020. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials |pdf=|usr=}}{{32415876}} gab.com Text Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials JO: Muscle Nerve http://www.kidney.de/pget.php?&tw=1&pmid=32415876 #FOAvip Amyotrophic lateral sclerosis (ALS) has the largest drug pipeline among neuromuscular diseases, with over 160 companies actively involved in ALS research. There is a growing need to recruit trial participants, but ALS patients often have limited mobility and most ALS trials are conducted in a small number of major centers. These factors effectively limit patient participation, particularly for those in rural areas. The current coronavirus disease 2019 (COVID-19) pandemic has necessitated the more widespread use of telemedicine technology for clinical care, and has prompted consideration of its increased use for clinical trials. In this opinion piece, we describe the current state of telemedicine for recruitment, consenting, and screening of participants for clinical trials. We also summarize the available data on remote administration of outcome measures. Current challenges include validation of outcome measures for remote assessment, as well as technological, regulatory, and licensure barriers. Twit Text FOAVip Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials ????Muscle Nerve http://www.kidney.de/pget.php?&tw=1&pmid=32415876 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32415876 #FOAvip English Wikipedia <ref>{{Cite pmid|32415876}}</ref> Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials #MMPMID32415876 Govindarajan R; Berry JD; Paganoni S; Pulley MT; Simmons Z Muscle Nerve 2020[Sep]; 62 (3): 321-326 PMID32415876show ga Amyotrophic lateral sclerosis (ALS) has the largest drug pipeline among neuromuscular diseases, with over 160 companies actively involved in ALS research. There is a growing need to recruit trial participants, but ALS patients often have limited mobility and most ALS trials are conducted in a small number of major centers. These factors effectively limit patient participation, particularly for those in rural areas. The current coronavirus disease 2019 (COVID-19) pandemic has necessitated the more widespread use of telemedicine technology for clinical care, and has prompted consideration of its increased use for clinical trials. In this opinion piece, we describe the current state of telemedicine for recruitment, consenting, and screening of participants for clinical trials. We also summarize the available data on remote administration of outcome measures. Current challenges include validation of outcome measures for remote assessment, as well as technological, regulatory, and licensure barriers. |*Betacoronavirus[MESH] |*Pandemics[MESH] |*Quality of Life[MESH] |Amyotrophic Lateral Sclerosis/complications/*diagnosis[MESH] |COVID-19[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/*complications/epidemiology[MESH] |Humans[MESH] |Pneumonia, Viral/*complications/epidemiology[MESH] |SARS-CoV-2[MESH]Optimizing telemedicine to facilitate amyotrophic lateral sclerosis cl(epmc).pdf DeepDyve Pubget Overpricing